Wild Bioscience raised €51M in a Series A round in Oct 2025. The company is based in Oxford, UK. Investors in the round: Ellison Institute of Technology (EIT). Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
